Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
1.710
+0.380 (28.57%)
At close: Aug 13, 2025, 4:00 PM
1.660
-0.050 (-2.92%)
Pre-market: Aug 14, 2025, 8:56 AM EDT

Cabaletta Bio Statistics

Total Valuation

Cabaletta Bio has a market cap or net worth of $156.41 million. The enterprise value is -$13.38 million.

Market Cap 156.41M
Enterprise Value -13.38M

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

Cabaletta Bio has 91.47 million shares outstanding. The number of shares has increased by 11.81% in one year.

Current Share Class 91.47M
Shares Outstanding 91.47M
Shares Change (YoY) +11.81%
Shares Change (QoQ) +21.94%
Owned by Insiders (%) 1.65%
Owned by Institutions (%) 44.99%
Float 81.12M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.88
P/TBV Ratio 0.88
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 4.78, with a Debt / Equity ratio of 0.14.

Current Ratio 4.78
Quick Ratio 4.69
Debt / Equity 0.14
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -92.92

Financial Efficiency

Return on equity (ROE) is -76.34% and return on invested capital (ROIC) is -45.66%.

Return on Equity (ROE) -76.34%
Return on Assets (ROA) -42.39%
Return on Invested Capital (ROIC) -45.66%
Return on Capital Employed (ROCE) -81.92%
Revenue Per Employee n/a
Profits Per Employee -$879,793
Employee Count 164
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -60.96% in the last 52 weeks. The beta is 2.74, so Cabaletta Bio's price volatility has been higher than the market average.

Beta (5Y) 2.74
52-Week Price Change -60.96%
50-Day Moving Average 1.71
200-Day Moving Average 2.12
Relative Strength Index (RSI) 57.71
Average Volume (20 Days) 1,303,091

Short Selling Information

The latest short interest is 6.03 million, so 6.59% of the outstanding shares have been sold short.

Short Interest 6.03M
Short Previous Month 6.54M
Short % of Shares Out 6.59%
Short % of Float 7.43%
Short Ratio (days to cover) 4.49

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -149.87M
Pretax Income -89.98M
Net Income -144.29M
EBITDA -148.03M
EBIT -149.87M
Earnings Per Share (EPS) -$2.75
Full Income Statement

Balance Sheet

The company has $194.68 million in cash and $24.89 million in debt, giving a net cash position of $169.79 million or $1.86 per share.

Cash & Cash Equivalents 194.68M
Total Debt 24.89M
Net Cash 169.79M
Net Cash Per Share $1.86
Equity (Book Value) 178.48M
Book Value Per Share 1.95
Working Capital 156.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$104.67 million and capital expenditures -$1.58 million, giving a free cash flow of -$106.25 million.

Operating Cash Flow -104.67M
Capital Expenditures -1.58M
Free Cash Flow -106.25M
FCF Per Share -$1.16
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Cabaletta Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.81%
Shareholder Yield -11.81%
Earnings Yield -92.25%
FCF Yield -67.93%

Analyst Forecast

The average price target for Cabaletta Bio is $14.29, which is 735.67% higher than the current price. The consensus rating is "Strong Buy".

Price Target $14.29
Price Target Difference 735.67%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -24.02%
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1